How to Build an Ongoing KOL Engagement Strategy in 3 Steps

Effective KOL engagement isn't a one-time interaction. For pharmaceutical and biotech clinical development and medical affairs teams, the most valuable KOL relationships develop through a series of relevant, well-planned interactions over time.

KOLs balance patient care, research, teaching, publications and other professional responsibilities, so every engagement needs to have a clear purpose and respect their time. A thoughtful KOL engagement strategy connects individual touchpoints, from advisory boards and investigator meetings to congress interactions and 1:1 discussions, into an ongoing relationship.

Here are three principles for creating meaningful, ongoing KOL engagement.

1. Understand the KOL's Scientific Interests and Priorities

Effective engagement starts with understanding the individual expert. Review their clinical research, recent publications, congress activity, society involvement and areas of scientific interest before planning an interaction.

Consider what questions are most relevant to their work. Are they focused on a particular patient population, clinical endpoint, mechanism of action or unmet need? Are they actively involved in clinical research or medical education? Understanding these priorities helps teams create conversations that are relevant rather than generic.

It is equally important to understand the KOL's perspective. Experts practicing in different regions, institutions and clinical settings may have very different experiences. Those differences are often exactly what make their perspectives valuable.

Preparation matters. When teams understand an expert's background and interests before an interaction, they can spend less time covering information the KOL already knows and more time having a meaningful scientific discussion.

2. Respect The KOL's Time

KOLs have significant demands on their time, and well-designed engagements demonstrate that their time and expertise are valued. Every interaction should have clear objectives, thoughtful preparation and a reason for that particular expert to participate.

A few considerations can make engagement more effective:

• Plan purposeful agendas. Build the agenda around the questions and insights you need rather than the amount of content you want to present.
• Bring the right internal stakeholders. Include the people necessary for a productive scientific exchange while avoiding an unnecessarily large company presence.
• Prepare presenters and facilitators. Rehearse content, anticipate areas of discussion and make sure everyone understands the meeting objectives and their role.
• Coordinate communication. Avoid having multiple people within the organization independently contacting the same KOL about overlapping initiatives.
• Meet experts where they are. Advisory boards, investigator meetings, congresses, virtual meetings and 1:1 conversations can all be valuable depending on the objective and the KOL's availability.

The goal isn't simply to increase the frequency of interaction. More engagement isn't necessarily better engagement. Each interaction should have a clear purpose and add value to the broader relationship.

3. Create Meaningful Opportunities for Engagement

Once you understand a KOL's interests and priorities, consider where their expertise can contribute meaningfully. Depending on the objectives of the program and the expert's experience, that might include an advisory board, investigator meeting, research initiative, publication, medical education program, congress engagement or individual scientific discussion.

The most effective KOL engagement strategies connect these interactions rather than treating them as isolated events. Insights from an advisory board might identify questions for a subsequent 1:1 discussion. A congress interaction might lead to a future scientific exchange. An investigator meeting may reveal perspectives that should be explored more deeply with investigators or external experts.

That continuity helps teams develop a richer understanding of external perspectives while creating engagement that remains relevant to the KOL.

Think Beyond the Individual Meeting

One of the biggest opportunities in KOL engagement is to think beyond individual meetings. A successful advisory board or congress interaction shouldn't necessarily be the end of the conversation. Consider what was learned, what questions remain and which experts may be appropriate for future engagement.

A well-designed KOL engagement plan creates continuity across touchpoints while still ensuring that every interaction has a distinct and legitimate purpose.

Ongoing KOL engagement requires more than frequent communication. It requires understanding the expert, respecting their time and creating thoughtful opportunities for scientific exchange. When those interactions are planned as part of a broader strategy, individual meetings can become part of meaningful, long-term KOL relationships.

SBHC partners with pharmaceutical and biotech clinical development and medical affairs teams to develop and execute KOL engagement strategies, including advisory boards, investigator meetings, congress engagements, roundtables, 1:1 interactions and other ongoing KOL initiatives.

Planning a KOL engagement program? Let's talk.